haemophilia
Novo Nordisk builds in haemophilia with Bluebird Bio gene editing deal
Phil Taylor
bluebird bio, gene editing, genetic, Haematology, haemophilia, Novo Nordisk
0 Comment
Catalyst’s rival to NovoSeven hits the mark in phase 2 haemophilia trial
Phil Taylor
Catalyst Biosciences, gene therapy, Haematology, haemophilia, Novo Nordisk, Sangamo Therapeutics, Takeda, uniQure
0 Comment
BioMarin seeks haemophilia gene therapy approval after promising data
George Underwood
BioMarin, gene therapy, haemophilia, valoctocogene roxaparvovec
0 Comment
Patients/ Views & Analysis/ Views and analysis
The unmet needs of bleeding disorder patients
Dominic Tyer
bleeding disorders, eyeforpharma, haemophilia
0 Comment
News/ News/ Patients/ Top stories
Gene therapy firm BioMarin stages haemophilia musical
Richard Staines
BioMarin, comms, haemophilia, Novo Nordisk, patients, Rare diseases, Roche, Shire
0 Comment
Debates & Insight/ Insights/ Patients/ White Papers/ Whitepapers
How pharma can boost engagement by embracing support networks
louise.bellamy@pharmaphorum.com
haemophilia, patient centricity, patient voice, pharma marketing, pharmaceutical branding, pharmaceutical industry marketing insights, support network
0 Comment